GLP-1R agonist 3

CAS No. 2428640-18-8

GLP-1R agonist 3( —— )

Catalog No. M35751 CAS No. 2428640-18-8

GLP-1R agonist 3 is a potent imidazole derivative and GLP-1R agonist with demonstrated research potential in diabetes. [Thickened]

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 195 Get Quote
5MG 297 Get Quote
10MG 487 Get Quote
25MG 908 Get Quote
50MG 1527 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GLP-1R agonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    GLP-1R agonist 3 is a potent imidazole derivative and GLP-1R agonist with demonstrated research potential in diabetes. [Thickened]
  • Description
    GLP-1R agonist 3 is a potent agonist of GLP-1R. GLP-1R agonist 3 is a thickened imidazole derivative compound. Glucagon-like peptide-1 (GLP-1) is an intestinal hypoglycemic hormone secreted by L-cells in the lower gastrointestinal tract. GLP-1R agonist 3 has the potential for the research of diabetes (extracted from patent WO2021197464A1, compound 1).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    Glucagon Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2428640-18-8
  • Formula Weight
    553.58
  • Molecular Formula
    C31H28FN5O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (225.80 mM; Ultrasonic )
  • SMILES
    C(N1C=2C(N=C1CN3CCC(=CC3)C=4N=C(OCC5=C(F)C=C(C#N)C=C5)C=CC4)=CC=C(C(O)=O)C2)[C@@H]6CCO6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fanglong Yang, et al. Thickened imidazole derivatives, methods of their preparation and their application in medicine. Patent WO2021197464A1.
molnova catalog
related products
  • HAEGTFTSDVS

    HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide.

  • GRA Ex-25

    A potent glucagon receptor inhibitor with IC50 of 56 and 55 nM for rat and human glucagon receptors.

  • MK-3577

    A potent, oral active glucagon receptor antagonist blocking the glucagon effect for the treatment of T2DM.